[Anonymous. (2009). Annual Report of the US Organ Procurement andTransplantation Network and the Science Registry of Transplant Recipients:Transplantation data 1999-2008. Department of health and human services, Rockville, MD.]Search in Google Scholar
[Anonymous. (2010). Eurotransplant International Foundation. Annual report 2010. Osterlee, A., Ramel, A. Central Office. Leiden. The Netherlands.]Search in Google Scholar
[Archdeacon, P., Chan, M., Neuland, C., Velidedeoglu, E., Meyer, J., Tracy, L., Cavaille-Coll, M., Bala, S., Hemandez, A., Albrecht, R. (2011). Summary of FDA Antibody-Mediated Rejection Workshop. Amer. J. Transplant., 11, 896-906.10.1111/j.1600-6143.2011.03525.x21521465]Search in Google Scholar
[Bartel, G., Wahrmann, M., Regel, H. (2010). Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Amer. J. Transplant., 10, 2033-2041.10.1111/j.1600-6143.2010.03226.x20883537]Search in Google Scholar
[Billen, E., Christiaans, M., van denBerg-Loonen, E. (2009). Clinical relevance of Luminex donor-specific crossmatches: Data from 165 renal transplants. Tiss. Antigens, 74 (3), 205-211.10.1111/j.1399-0039.2009.01283.x19497037]Search in Google Scholar
[Bruce, V., Suranyi, M. (1995). Understanding rejection. In: The Handbook ofTransplant Immunology. Wood, K. (ed.) MedSci, Oxford, pp. 113-133.]Search in Google Scholar
[Burns, J., Cornell, L., Perry, D., Pollinger, H., Gloor, J. (2008). Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Amer. J. Transplant., 8, 2684-2694.10.1111/j.1600-6143.2008.02441.x18976305]Search in Google Scholar
[Cecka, J. (2011). Current methodologies for detection sensitization to HLA antigens. Curr. Opin. Organ Transplant., 16, 398-411.10.1097/MOT.0b013e328348980a21666477]Search in Google Scholar
[Chapmen, J., Taylor, C., Ting, A., Morris, P. (1986). Hypereacute rejection of renal allograft in the presence of anti-HLA Cw5 antibody. Transplantation, 42, 91-95.10.1097/00007890-198607000-00022]Search in Google Scholar
[Claas, F., Rahmel, A., Doxiadis, I. (2009). Enhanced kidney allocation to highly sentized patients by the acceptable mismatch program. Transplantation, 88, 447-45310.1097/TP.0b013e3181b04a5f19696624]Search in Google Scholar
[Clatworthy, M. R. (2011). Targeting B cells and antibody in transplantation. Amer. J. Transplant., 11, 1359-1367.10.1111/j.1600-6143.2011.03554.x414861821668625]Search in Google Scholar
[Collins, A., Scheeberger, E., Pascual, M. (1999). Compliment activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J. Amer. Soc, Nephol., 10, 2208-2215.10.1681/ASN.V1010220810505698]Search in Google Scholar
[Colvin, R. (2007). Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J. Amer. Soc. Nephrol., 18, 1046-1056.10.1681/ASN.200701007317360947]Search in Google Scholar
[Danovitch, G. (ed.). (2010). Handbook of Kidney Transplantation. Philadelphia: Wolter Kluwer. 471 pp.]Search in Google Scholar
[Dragun, D., Muller, D., Brasen, M. (2005). Angiotensin II Type I-receptor activating antibodies in renal allograft rejection. New Engl. J. Med., 352, 558-569.10.1056/NEJMoa03571715703421]Search in Google Scholar
[Einecke, G., Sis, B., Reeve, J., Mengel, M., Husain, S. (2009). Antibody- mediated microcirculation injury is the major cause of late kidney transplant failure. Amer. J. Transplant., 9, 2520-2509.10.1111/j.1600-6143.2009.02799.x19843030]Search in Google Scholar
[Everly, M., Terasaki, P., Trivedt, H. (2012). Durability of antibody removal following proteasome inhibitor-based therapy. Transplantation, 93, 572-577.10.1097/TP.0b013e31824612df22262128]Search in Google Scholar
[Fehr, T., Gaspert, A. (2012). Antibody-mediated kidney allograft rejection: Therapeutic options and their experimental rationale. Transplant. Int., 25, 623-632.10.1111/j.1432-2277.2012.01453.x22394269]Search in Google Scholar
[Feucht, H, Schneeberger, H, Hillebrand, G. (1993). Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int., 43, 1333-1341.10.1038/ki.1993.1878315947]Search in Google Scholar
[Fuggle, S., Martin, S. (2008). Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation, 86, 384-389.10.1097/TP.0b013e31817c90f518698240]Search in Google Scholar
[Gaston, R., Cecka, J., Kasiske, B. (2010). Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation, 90, 68-7610.1097/TP.0b013e3181e065de20463643]Search in Google Scholar
[Gebel, H., Bray, R. (2000). Sensitization and sensitivity: Defining the unsensitized patient. Transplantation, 69, 1370-1374.10.1097/00007890-200004150-0002710798756]Search in Google Scholar
[Gloor, J., Sethi, S., Stegall, M., Cosio, F., Rea, D. (2007). Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Amer. J. Transplant., 7, 2124-2130.10.1111/j.1600-6143.2007.01895.x17608832]Search in Google Scholar
[Halloran, P., de Freitas, D., Einecke, G., Solez, K., Ritchie, A. (2010). An integrated view of molecular changes, histopathology and outcomes in kidney transplant Amer. J. Transplant., 10, 2223-2230.]Search in Google Scholar
[Halloran, P., Wadgymar, A., Ritchie, S., Falk, J., Solez, K., Srinivasa, N. (1990). The significance of anti-class I antibody response. I. Clinical and pathologic features of anti-class I- mediated rejection. Transplantation, 49, 85-89.10.1097/00007890-199001000-000192301035]Search in Google Scholar
[Hricik, D. (ed.). (2011). Primer of Transplantation. Willey-Blackwell, UK. 307 pp.10.1002/9781444391770]Search in Google Scholar
[Kamar, N., Milioto, O., Puissant-Librano, B., Esposito, L., Pierre, M. C., Mohamed, A. O., Lavayssière, L., Cointault, O., Ribes, D., Cardeau, I., Nogier, M. B., Durand, D., Abbal, M., Blancher, A., Rostaing, L. (2010). Incidence and predictive factors for infections disease after rituximab therapy in kidney-transplant patients. Amer. J. Transplant., 10, 89-98.10.1111/j.1600-6143.2009.02785.x19656128]Search in Google Scholar
[Lefaucheur, C., Suberbielle-Boissel, C., Hill, G. (2009). Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib. Nephrol., 162, 1-11.]Search in Google Scholar
[Lefaucheur, C., Loupy, A., Hill, G. (2010). Preexisiting donor-specific HLA antibodies predict outcome in kidney transplantation. J. Amer. Soc. Nephrol., 21, 1398-1407.10.1681/ASN.2009101065293859620634297]Search in Google Scholar
[Lefaucheur, C., Antonie, C., Suberbielle, C., Glotz, D. (2011). Mastering the risk of HLA antibodies in kidney transplantation: An algorithm based on pretransplant single-antigen flow bead techniques. Amer. J. Transplant., 11, 1592-1598.10.1111/j.1600-6143.2011.03560.x21668626]Search in Google Scholar
[Loupy, A., Suberbielle-Boissel, C., Hill, G., Nochy, D. (2009). Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Amer. J. Transplant., 9, 2561-2570.10.1111/j.1600-6143.2009.02813.x19775320]Search in Google Scholar
[Loupy, A., Hill, G., Suberbielle, C. (2011). Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with performed donor-specific antibodies (DSA). Amer. J. Transplant., 11, 56-67.10.1111/j.1600-6143.2010.03364.x21199348]Search in Google Scholar
[Mao, Q., Terasaki, P., Cai, J. (2007). Extremely high association between appearance of HLA antobodies and failure of kidney graft in a five-year longitudinal study. Amer. J. Transplant., 7, 864-875.10.1111/j.1600-6143.2006.01711.x17391129]Search in Google Scholar
[Marrari, M., Duquesnoy, R. (2010). Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transplant. Immunol., 22, 105-111.10.1016/j.trim.2009.12.00520035868]Search in Google Scholar
[McDonald, S., Russ, G., Campbell, S., Chadban, S. (2007). Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Amer. J. Transplant., 7, 1201-1208.10.1111/j.1600-6143.2007.01759.x17359502]Search in Google Scholar
[Mengel, M., Sis, B., Haas, M., Colvin, R., Halloran, P., Racusen, L. (2012). Banff 2011 meeting report: New concepts in antibody-mediated rejection. Amer. J. Transplant., 12, 563-570.10.1111/j.1600-6143.2011.03926.x372865122300494]Search in Google Scholar
[Mengel, M., Husain, S., Hidalgo, L., Sis, B. (2012). Phenotypes of antibody- mediated rejection in organ transplant. Transplant. Int., 25, 611-622.10.1111/j.1432-2277.2012.01484.x22533649]Search in Google Scholar
[Montgomery, R. (2010). Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Amer. J. Transplant., 10, 449-458.10.1111/j.1600-6143.2009.03001.x20121749]Search in Google Scholar
[Morath, C., Opelz, G., Zeier, M., Susal, C. (2012). Prevention of antibody- mediated kidney transplant rejection. Transplant. Int., 25, 633-645.10.1111/j.1432-2277.2012.01490.x22587522]Search in Google Scholar
[Muthukumar, T., Mueller, F., Anglicheau, D., Sharma, V., Ding, R., Suthanthiran, M. (2011). Intragraft microRNA expression signatures of interstitial fibrosis and tubular athrophy of human renal allograft. Amer. J. Transplant., 10, 291-298.]Search in Google Scholar
[Navkivel, B., Alexander, S. (2010). Mechanisms of disease: Rejection of kidney allograft. New Engl. J. Med., 363, 1451-1461.10.1056/NEJMra090292720925547]Search in Google Scholar
[Poduval, R., Kadambi, P., Josephson, M., Cohn, R., Harald, R. (2005). Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation, 79, 228-235.10.1097/01.TP.0000148987.13199.10]Search in Google Scholar
[Roelen, D., Doxiadis, I., Claas, F. (2012). Detection and clinical relevance of donor specific HLA antibodies: A matter of debate. Transplant. Int., 25, 604-610.10.1111/j.1432-2277.2012.01491.x22587521]Search in Google Scholar
[Schnaidt, M., Weinstock, C., Jurisic, M., Schmidt-Horch, B., Ender, A, Wernet, D. (2011). HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation, 92, 510-515.10.1097/TP.0b013e31822872dd21869744]Search in Google Scholar
[Sellares, J., de Frietas, D., Mengel, M., Reeve, J., Matas, A., Halloran, P. (2012). Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Amer. J. Transplant., 12, 388-399.10.1111/j.1600-6143.2011.03840.x22081892]Search in Google Scholar
[Shehata, N., Palda, V., Meyer, R. (2010). The use of immunoglobulin therapy for patients undergoing solid organ transplantation: An evidence-based practice guideline. Transfuse Med. Rev., 24 (suppl.1) S7.10.1016/j.tmrv.2009.09.01019962580]Search in Google Scholar
[Sis, B., Jhangri, G., Riopel, J., Chang, D., de Freitas, D. G., Hidalgo, L., Mengel, M., Matas, A., Halloran, P. F. (2012). A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplant. Amer. J. Transplant., 12, 1168-1179.10.1111/j.1600-6143.2011.03931.x22300601]Search in Google Scholar
[Stegall, M., Gloor, J., Winters, J., Moore, S., Degoey, S. (2006). A comparison of plasmapheresis versus high dose IVIG desensitization in renal allograft recipients with high levels of donor-specific alloantibody. Amer. J. Transplant., 6, 346-353.10.1111/j.1600-6143.2005.01178.x16426319]Search in Google Scholar
[Stegall, M., Dean, P., Gloor, J. (2009). Mechanisms of alloantibody production to sensitized renal allograft recipients. Amer. J. Transplant., 9, 998-1006.10.1111/j.1600-6143.2009.02612.x19422329]Search in Google Scholar
[Susal, C., Dohler, B., Opelz, G. (2009). Presensitized kidney graft recipient with HLA class I and II antibodies are at increased risk for graft failure: A collaborative transplant study report. Hum. Immunol., 70, 59-67.10.1016/j.humimm.2009.04.01319375472]Search in Google Scholar
[Terasaki, P. (2003). Humoral theory of transplantation. Amer. J. Transplant., 3, 665-673.10.1034/j.1600-6143.2003.00135.x12780557]Search in Google Scholar
[Tripkov, K., Cambell, P., Pazderka, F., Cocfield, S., Solez, K., Halloran, P. (1996). Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation, 61, 1586-1591.10.1097/00007890-199606150-000078669102]Search in Google Scholar
[Vaidya, S., Partlow, D., Susskind, B., Noor, M., Barnes, T., Gugliuzza, K. (2006). Prediction of cross-match outcome in highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation, 82, 1524-1532.10.1097/01.tp.0000246311.43634.0a17164726]Search in Google Scholar
[Venetz, J., Pascual, M. (2007). New treatments for acute humoral rejection in kidney allograft. Expert Opin. Investing. Drugs., 16, 625-632.10.1517/13543784.16.5.62517461736]Search in Google Scholar
[Wiebe, C., Gibson, I., Blydt-Hansen, T., Karpinski, M., Ho, J. (2012). Evolution and clinical pathologic correlation of de novo donor-specific HLA antibody post kidney transplant. Amer. J. Transplant., 12, 1157-1167.10.1111/j.1600-6143.2012.04013.x22429309]Search in Google Scholar
[Zachary, A., Montgomery, R., Ratner, L., Racusen, L. (2003). Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation, 76, 1519-1525.10.1097/01.TP.0000090868.88895.E014657698]Search in Google Scholar
[Zachary, A., Lucas, D., Detrick, B., Leffel, M. (2009). Naturally occurring interference in Luminex assay for HLA-specific antibodies: Characteristics and resolution. Hum, Immunol., 70, 496-502.10.1016/j.humimm.2009.04.00119364516]Search in Google Scholar
[Zeevi, A., Girnita, A., Duquesnoy, R. (2006). HLA antibody analysis: Sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol. Res., 36, 255-264.10.1385/IR:36:1:255]Search in Google Scholar
[Zou, Y., Stasny, P., Susal, C., Dohler, B., Opelz, G. (2007). Antibodies against MICA antigens and kidney transplant rejection. New Engl. J. Med.,357, 1293-3000.10.1056/NEJMoa067160]Search in Google Scholar